DL-trans-3,4-Dihydroxy-1-selenolane (DHSred) accelerates healing of indomethacin-induced stomach ulceration in mice

Free Radical Research

Volumn 46, Issue 11, 2012, Pages 1378-1386

  Chakraborty, Saikat ^a   Yadav, Sudhir K ^a   Subramanian, Mahesh ^a   Priyadarsini, Kavirayani I ^a   Iwaoka, Michio ^b   Chattopadhyay, Subrata ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Antioxidant; COX; Mucin; Non steroidal anti inflammatory drugs; Non steroidal gastric ulcer; Prostagalindin

Indexed keywords

3,4 DIHYDROXY 1 SELENOLANE; ANTIULCER AGENT; GLUTATHIONE PEROXIDASE; INDOMETACIN; MUCIN; OMEPRAZOLE; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; STOMACH; STOMACH MUCOSA; STOMACH ULCER; ULCER HEALING; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; HETEROCYCLIC COMPOUNDS, 1-RING; IMMUNOBLOTTING; INDOMETHACIN; MALE; MICE; ORGANOSELENIUM COMPOUNDS; STOMACH ULCER;

EID: 84867512815     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.718766     Document Type: Article

References (37)

1. Wallace J L. N SAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Brit J Pharmacol 2011. doi:10.1111/j.1476-5381.2011.01509.x.
2. Brooks P, E mery P, E vans JF, F enner H, H awkey CJ, P atrono C, et al. Interpreting the clinical signifi cance of the differential inhibition of COX-1 and COX-2. Rheumatol 1999; 38: 779-788.
3. Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N. The antiplatelet effect of six non-steroidal anti-infl ammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. Am J Cardiol 2008; 101: 1060-1063.
4. Piazza GA, K eeton AB, T insley HN, W hitt JD, G ary BD, M athew B, et al. NSAIDs: old drugs reveal new anticancer targets. Pharmaceuticals 2010; 3: 1652-1667.
5. Roth SH. Nonsteroidal anti-infl ammatory drug gastropathy: we started it, why don't we stop it? J Rheumatol 2005; 32: 1189-1191.
6. Miederer S E. W ill anti-ulcer drugs soon differ only in their side effects? Fortschr Med 1986; 104: 918-920.
7. Chan FKL. P rimer: managing NSAID-induced ulcer complications - balancing gastrointestinal and cardiovascular risks. Nature Clin Practice Gastroenterol Hepatol 2006; 3: 563-573.
8. Holecek V, R okyta R, V lasak R. A ntioxidants and their gastrointestinal absorption and interferences of their effects. Cesk Fysiol 2008; 57: 24-32.
9. Garcia S M. O rganoselenium compounds as potential therapeutic and chemopreventive agents: a review. Curr Med Chem 2004; 11: 1657-1669.
10. Ayyanar M, I gnacimuthu S. P harmacological actions of C assia auriculata L and Cissus quadrangularis wall. J Pharmacol Toxicol 2008; 3: 213-221.
11. Santhosh Kumar B, K unwar A, A hmad A, K umbhare L B, Jain VK, Priyadarsini KI. Radioprotection of biomolecules by organoselenium compounds - differences between mono and diselenides. Rad Environ Biophys 2009; 48: 379-384.
12. Fiskin K, O zkan A, A yhan A G. I nvestigation of protective effects of selenium and vitamin E against DNA oxidation, membrane damage and alteration of COMT metabolism in smoke-exposed male mice ( Mus musculus, Balb/c). Acta Biol Hung 2006; 57: 403-413.
13. Banner WP, D eCosse JJ, T an QH, Z edeck MS. S elective distribution of selenium in colon parallels its antitumor activity. Carcinogenesis 1984; 5: 1543-1546.
14. Slootmans I L, Dirk A, Berghe V, Dyck EV, Piot P. S usceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products. Antimicrob Agents Chemother 1983; 24: 564-567.
15. Iwaoka M, T akahashi T, T omoda S. S ynthesis and structural characterization of water-soluble selenium reagents for the redox control of protein disulfi de bonds. Heteroatom Chem 2001; 12: 293-299.
16. Kumakura F, M ishra B, P riyadarsini KI, I waoka M. A watersoluble cyclic selenide with enhanced glutathione peroxidase-like catalytic activities. Eur J Org Chem 2010: 440-445.
17. Yoshikawa T, N aito Y, K ishi A, T omii T, K aneko T, I inuma S, et al. Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993; 34: 732-737.
18. Miura T, M uraoka S, F ujimoto Y. L ipid peroxidation induced by indomethacin with horseradish peroxidase and hydrogen peroxide: involvement of indomethacin radicals. Biochem Pharmacol 2002; 63: 2069-2074.
19. Miller TA. P rotective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983; 245: G601-G623.
20. Adhikari B, Yadav SK, Roy K, Bandyopadhyay SK, Chattopadhyay S. Black tea and theafl avins assist healing of indomethacin-induced gastric ulceration in mice by antioxidative action. Evidence-Based Compl Alt Med (eCAM) 2010; 2011: Article ID 546560, doi:10.1155/2011/546560.
21. Banerjee D, Maity B, Bauri A K, Bandyopadhyay SK, Chattopadhyay S. Gastroprotective property of Myristica malabarica against indomethacin-induced stomach ulceration: A mechanistic exploration. J Pharm Pharmacol 2007; 59: 1555-1565.
22. Dokmeci D, A kpolat M, A ydogu N, Doganay L, Turan FN. L-Carntine inhibits ethanol-induced gastric mucosal injury in rats. Pharmacol Rep 2005; 57: 481-488.
23. S warnakar S, G anguly K, K undu P, B anerjee A, M aity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 2005; 280: 9409-9415.
24. Sedlak J, L indsay RH. E stimation of total protein-bound, and non-protein sulphydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
25. Newaz MA, N awal NNA. E ffect of a-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 1480-1485.
26. Tariq M, A l Moutaery A. M enadione protects gastric mucosa against ethanol-induced ulcers. Exp Toxicol Pathol 2005; 56: 393-399.
27. McManus J FA. H istological demonstration of mucin after periodic acid. Nature 1946; 158: 202-202.
28. Rainsford KD. T he effects of aspirin and other nonsteroid antiinfl ammatory analgesic drugs on gastrointestinal mucus glycoprotein biosynthesis in vivo: relationship to ulcerogenic actions. Biochem Pharmacol 1978; 27: 877-885.
29. Avila JR, d e la Lastra CA, M artin MJ, M otilva V, L uque I, Delgado D, et al. Role of endogenous sulphydryls and neutrophil infi ltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats. Infl amm Res 1996; 45: 83-88.
30. Bertrand V, Guessous F, Le Roy AL, V iossat B, F essi H, El Abbouyi A, et al. Copper-indomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats: Effect on inducible no synthase on inducible no synthase Dig Dis Sci 1999; 44; 991-999.
31. Ghiselli A, S erafi ni M, N atella F, S caccini C. T otal antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000; 29: 1106-1114.
32. Halter F, S chamassman A, Peskar BM, T arnawski A S. C yclooxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing: controversies and perspectives. Gut 2001; 49: 443-453.
33. Wallace JL. Nonsteroidal anti-infl ammatory drugs and gastroenteropathy: the second hundred years. Gastroenterol 1997; 112: 1000-1016.
34. Jones MK, Wang H, Peskar BM, L evin E, I tani RM, S arfeh IJ, Tarnawski AS. Inhibition of angiogenesis by nonsteroidal antiinfl ammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418-1423.
35. Hassan S, K inoshita Y, M in D, N akata H, K ishi K, M atsushima Y, et al. Presence of prostaglandin EP4 receptor gene expression in a rat gastric mucosal cell line. Digestion 1996; 57: 196-200.
36. Goldstein J L, J ohanson J F, H awkey C J, S uchower L J, B rown K A. Clinical trial: Healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy-A randomized study comparing ranitidine with esomeprazole. Aliment Pharmacol Ther 2007; 26: 1101-1111.
37. Takeuchi Y, K itano S, B andoh T, M atsumoto T, B aatar D, K ai S. Acceleration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation? Eur Surg Res 2003; 35: 75-80.